Baker Brothers Advisors - SYNERGY PHARMACEUTICALS DEL ownership

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of SYNERGY PHARMACEUTICALS DEL
ValueSharesWeighting
Q3 2015$356,000
-88.0%
67,100
-93.1%
0.00%
-90.0%
Q4 2014$2,968,000
+9.5%
973,2450.0%0.03%
-11.8%
Q3 2014$2,710,000
-62.1%
973,245
-44.6%
0.03%
-61.4%
Q2 2014$7,156,000
-23.4%
1,758,2710.0%0.09%
-26.1%
Q1 2014$9,336,000
-36.4%
1,758,271
-32.6%
0.12%
-42.5%
Q4 2013$14,685,000
+23.2%
2,608,2710.0%0.21%
+22.5%
Q3 2013$11,920,000
+5.8%
2,608,2710.0%0.17%
-24.2%
Q2 2013$11,268,0002,608,2710.22%
Other shareholders
SYNERGY PHARMACEUTICALS DEL shareholders Q3 2023
NameSharesValueWeighting ↓
CVI Holdings, LLC 1,767,858$3,235,0004.39%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 1,505,809$2,726,0001.06%
Nantahala Capital Management 11,578,568$21,189,0000.96%
Hikari Power Ltd 2,000,000$3,660,0000.43%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,376,708$2,519,0000.20%
KNOTT DAVID M 225,400$412,0000.17%
Truepoint, Inc. 37$20,000,0000.16%
Clear Harbor Asset Management, LLC 283,560$519,0000.10%
Malaga Cove Capital, LLC 97,266$178,0000.10%
Lehman Financial Resources, Inc. 70,800$129,0000.07%
View complete list of SYNERGY PHARMACEUTICALS DEL shareholders